In2Pharma
  • Home
  • Services
    • Regulatory Affairs
    • Quality Assurance
    • Publicity and Compliance
    • Medical writing & training
    • Vigilance
  • About Us
  • News
  • Contact
Select Page
APL will change names to IML: Innovative Medicines for Luxembourg

APL will change names to IML: Innovative Medicines for Luxembourg

by In2Pharma | Feb 17, 2022 | News

Luxembourg APL, the Association Pharmaceutique Luxembourgeoise, is a Luxembourg-based association founded in 2011. The APL’s mission is to promote better healthcare by encouraging therapeutic innovation in the field of medicines for human use in Luxembourg. It...

Recent Posts

  • Price display of OTC medicines
  • New fees for food supplement notifications
  • Revision IML Code of Ethics
  • New guideline on the use of D-mannose in food supplements
  • Adjusted fees for applications to EMA

Follow Us

  • Facebook
  • LinkedIn
Privacy Policy | Cookie Policy | BTW BE 895730662 | +32 16 89 16 00| info@in2pharma.com | Terloonststraat 22, 1910 Kampenhout, België